Funabashi, Japan

Yukihiro Shigeta

USPTO Granted Patents = 13 


Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yukihiro Shigeta

Introduction

Yukihiro Shigeta is a prominent inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate the thrombopoietin receptor. With a total of 13 patents to his name, Shigeta's work has the potential to impact the treatment of various diseases.

Latest Patents

Shigeta's latest patents include innovative compounds designed for the prevention and treatment of diseases where thrombopoietin receptor activation is beneficial. One of his notable inventions is a fused heterocyclic compound, which is represented by a specific formula. This compound, along with its tautomer, prodrug, or pharmaceutically acceptable salt, offers promising therapeutic applications. Another significant patent involves 3-ethylidenehydrazino substituted heterocyclic compounds, which also serve as thrombopoietin receptor activators. These compounds are similarly defined by a specific formula and hold potential for medical advancements.

Career Highlights

Yukihiro Shigeta is currently associated with Nissan Chemical Industries Limited, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a strong focus on creating effective compounds that can lead to improved health outcomes.

Collaborations

Shigeta collaborates with esteemed colleagues in his field, including Kazufumi Yanagihara and Kazuhiko Ohrai. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Yukihiro Shigeta's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key inventor. His work on thrombopoietin receptor activators showcases the potential for significant advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…